U.S. flag

An official website of the United States government

NM_000540.3(RYR1):c.14558C>A (p.Thr4853Asn) AND RYR1-related disorder

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 15, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002820024.3

Allele description [Variation Report for NM_000540.3(RYR1):c.14558C>A (p.Thr4853Asn)]

NM_000540.3(RYR1):c.14558C>A (p.Thr4853Asn)

Gene:
RYR1:ryanodine receptor 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.2
Genomic location:
Preferred name:
NM_000540.3(RYR1):c.14558C>A (p.Thr4853Asn)
HGVS:
  • NC_000019.10:g.38580416C>A
  • NG_008866.1:g.151717C>A
  • NM_000540.3:c.14558C>AMANE SELECT
  • NM_001042723.2:c.14543C>A
  • NP_000531.2:p.Thr4853Asn
  • NP_000531.2:p.Thr4853Asn
  • NP_001036188.1:p.Thr4848Asn
  • LRG_766t1:c.14558C>A
  • LRG_766:g.151717C>A
  • LRG_766p1:p.Thr4853Asn
  • NC_000019.9:g.39071056C>A
  • NM_000540.2:c.14558C>A
Protein change:
T4848N
Molecular consequence:
  • NM_000540.3:c.14558C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001042723.2:c.14543C>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
RYR1-related disorder
Synonyms:
RYR1-Related Disorders; RYR1-related condition
Identifiers:
MedGen: CN239331

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003210958Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 15, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

[Malignant hyperthermia--a hereditary and potentially life-threatening condition].

Haugen T, Toft M, Müller CR, Aasly J.

Tidsskr Nor Laegeforen. 2005 Oct 20;125(20):2792-4. Norwegian.

PubMed [citation]
PMID:
16244682

Congenital myopathies--clinical features and frequency of individual subtypes diagnosed over a 5-year period in the United Kingdom.

Maggi L, Scoto M, Cirak S, Robb SA, Klein A, Lillis S, Cullup T, Feng L, Manzur AY, Sewry CA, Abbs S, Jungbluth H, Muntoni F.

Neuromuscul Disord. 2013 Mar;23(3):195-205. doi: 10.1016/j.nmd.2013.01.004. Epub 2013 Feb 8.

PubMed [citation]
PMID:
23394784
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003210958.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change replaces threonine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 4853 of the RYR1 protein (p.Thr4853Asn). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of autosomal dominant congenital myopathy (Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 2001954). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RYR1 protein function with a positive predictive value of 95%. This variant disrupts the p.Thr4853 amino acid residue in RYR1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 16244682, 23394784; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024